We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.1B
AUM Growth
+$1.76B
Cap. Flow
+$154M
Cap. Flow %
0.81%
Top 10 Hldgs %
32.12%
Holding
703
New
28
Increased
257
Reduced
281
Closed
39

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$60.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$58.3M
3
SCHW
Charles Schwab
SCHW
+$54M
4
ABBV icon
AbbVie
ABBV
+$52.9M
5
PANW icon
Palo Alto Networks
PANW
+$42.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$92.7M
2
EMR icon
Emerson Electric
EMR
+$57.2M
3
MELI icon
Mercado Libre
MELI
+$48.9M
4
AVGO icon
Broadcom
AVGO
+$38.9M
5
MU icon
Micron Technology
MU
+$37.7M

Sector Composition

Rank Sector Weight
1 Technology 36.63%
2 Healthcare 23.08%
3 Financials 11.48%
4 Consumer Discretionary 7.78%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.95T
$1.35B 7.06%
2,603,908
+20,981
+0.8% +$10.7M
NVDA icon
2
NVIDIA
NVDA
$5.02T
$1.29B 6.74%
6,895,919
-532,075
-7% -$92.7M
AAPL icon
3
Apple
AAPL
$4.81T
$866M 4.54%
3,402,027
-14,058
-0.4% -$3.18M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.24T
$574M 3%
2,360,820
+27,331
+1% +$5.72M
AMZN icon
5
Amazon
AMZN
$2.66T
$513M 2.69%
2,337,689
+143,383
+7% +$32.5M
AVGO icon
6
Broadcom
AVGO
$1.84T
$475M 2.49%
1,440,554
-126,704
-8% -$38.9M
LLY icon
7
Eli Lilly
LLY
$1.05T
$351M 1.84%
460,092
-716
-0.2% -$533K
MA icon
8
Mastercard
MA
$476B
$246M 1.29%
431,879
-12,676
-3% -$7.28M
TSM icon
9
TSMC
TSM
$2.2T
$243M 1.27%
870,862
+9,833
+1% +$2.4M
META icon
10
Meta Platforms (Facebook)
META
$1.63T
$232M 1.22%
316,132
-41,777
-12% -$31.1M
GOOG icon
11
Alphabet (Google) Class C
GOOG
$4.22T
$218M 1.14%
895,913
-54,853
-6% -$11.5M
JPM icon
12
JPMorgan Chase
JPM
$918B
$212M 1.11%
672,749
-14,700
-2% -$4.37M
PANW icon
13
Palo Alto Networks
PANW
$279B
$211M 1.1%
1,035,212
+224,315
+28% +$42.9M
ABBV icon
14
AbbVie
ABBV
$452B
$194M 1.01%
835,716
+259,924
+45% +$52.9M
V icon
15
Visa
V
$677B
$184M 0.96%
537,784
+36,443
+7% +$12.6M
GILD icon
16
Gilead Sciences
GILD
$162B
$180M 0.94%
1,620,397
+110,559
+7% +$12.6M
ABT icon
17
Abbott
ABT
$174B
$157M 0.82%
1,172,360
+125,477
+12% +$16.5M
CRM icon
18
Salesforce
CRM
$139B
$155M 0.81%
654,166
-93,369
-12% -$23.5M
NOW icon
19
ServiceNow
NOW
$105B
$153M 0.8%
833,380
+213,545
+34% +$39.9M
LRCX icon
20
Lam Research
LRCX
$403B
$149M 0.78%
1,112,155
+81,888
+8% +$8.67M
MCK icon
21
McKesson
MCK
$97.3B
$147M 0.77%
190,186
+39,586
+26% +$27.9M
PG icon
22
Procter & Gamble
PG
$345B
$138M 0.72%
900,708
-191,990
-18% -$30M
HD icon
23
Home Depot
HD
$331B
$137M 0.72%
337,853
+20,373
+6% +$8.01M
TSLA icon
24
Tesla
TSLA
$1.42T
$133M 0.69%
298,260
+49,366
+20% +$17.1M
TMO icon
25
Thermo Fisher Scientific
TMO
$195B
$132M 0.69%
272,114
-65,359
-19% -$30.4M

Similar funds

Candriam SCA's Q3 2025 Portfolio in Review

As of Q3 2025, Candriam SCA held 703 positions worth $19.1B, up 10% from $17.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q3 2025 filing shows 28 new, 257 increased, 281 reduced and 39 closed positions. Its largest new stake was Banco Macro: 322,600 shares worth $13.6M. The largest sale was NVIDIA, an estimated $92.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2025 buy was Banco Macro: 322,600 shares worth $13.6M.
  • Candriam SCA added most to Nu Holdings in Q3 2025, an estimated $60.7M increase.
  • Candriam SCA's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $92.7M.
  • Candriam SCA fully exited Verona Pharma in Q3 2025, selling an estimated $20.5M.
  • Candriam SCA's ten largest holdings make up 32% of its $19.1B portfolio in Q3 2025.
  • Candriam SCA opened 28 new positions and closed 39 in Q3 2025.
  • Candriam SCA's portfolio value rose 10% quarter-over-quarter to $19.1B.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.